Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia

Authors:

Abstract
Background. Bayesian evolutionary analysis (coalescent analysis) based on genetic sequences has been used to describe the origins and spread of rapidly mutating RNA viruses, such as influenza, Ebola, human immunodeficiency virus (HIV), and hepatitis C virus (HCV). Methods. Full-length subtype 1a and 3a sequences from early HCV infections from the International Collaborative of Incident HIV and Hepatitis C in Injecting Cohorts (InC3), as well as from public databases from a time window of 1977–2012, were used in a coalescent analysis with BEAST software to estimate the origin and progression of the HCV epidemics in Australia and North America. Convergent temporal trends were sought via independent epidemiological modeling. Results. The epidemic of subtype 3a had more recent origins (around 1950) than subtype 1a (around 1920) in both continents. In both modeling approaches and in both continents, the epidemics underwent exponential growth between 1955 and 1975, which then stabilized in the late 20th century. Conclusions. Historical events that fuelled the emergence and spread of injecting drug use, such as the advent of intravenous medical therapies and devices, and growth in the heroin trade, as well as population mixing during armed conflicts, were likely drivers for the cross-continental spread of the HCV epidemics.
Funding Information
  • National Institute on Drug Abuse
  • National Institutes of Health
  • Norges Idrettshøgskole
  • National Institute on Drug Abuse (R01 DA031056)
  • Netherlands National Institute for Public Health and the Environment to the Amsterdam Cohort Study
  • Baltimore Before and After Study
  • Norges Idrettshøgskole (U19 AI088791)
  • Boston Acute HCV Study: Transmission, Immunity, Outcomes Network
  • BAHSTION
  • National Institute of Allergy and Infectious Diseases (U19 AI066345)
  • Australian Trial in Acute Hepatitis C
  • National Institute on Drug Abuse (15999-01)
  • Hepatitis Incidence and Transmission Study in prisons
  • National Health and Medical Research Council of Australia [NHMRC] (222887, 1016351, 510488, 1053206)
  • Hepatitis Incidence and Transmission Study in community
  • University of New South Wales Hepatitis C Vaccine Initiative and NHMRC (630483)
  • Networks/MIX (NHMRC (331312, 545891)
  • Victorian Operational Infrastructure Support Programme, Department of Health, Victoria, Australia
  • Canadian Institutes of Health Research (MOP-103138, MOP-106468)
  • Réseau SIDA Maladies Infectieuses, Fonds de la Recherche du Québec-Santé
  • U-Find-Out
  • Norges Idrettshøgskole (R01 DA016017)

This publication has 41 references indexed in Scilit: